Categories AlphaGraphs, Earnings, Health Care
Johnson & Johnson (JNJ) Q2 2023 Earnings: Key financials and quarterly highlights
Johnson & Johnson (NYSE: JNJ) reported second quarter 2023 earnings results today.
Reported sales increased 6.3% year-over-year to $25.5 billion.
GAAP net earnings rose 6.9% to $5.1 billion while EPS grew 8.9% to $1.96 compared to last year. Adjusted EPS rose 8.1% to $2.80.
Both revenue and earnings beat expectations.
For the full year of 2023, the company expects adjusted EPS to range between $10.70-10.80.
The stock gained over 1% in premarket hours on Thursday following the earnings report.
Prior performance
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
